Anna Berkenblit, SVP & Chief Medical Officer at ImmunoGen, Inc. (IMGN), sold 51,606 shares at $4.99 ($258K) on 2020-02-24, disclosed to the SEC on 2020-02-25.
Seasonal sale ($258k) by SVP & Chief Medical Officer — this insider has traded IMGN in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.99 | 25,803 | $129K | 50.0% |
| 2 | $4.99 | 25,803 | $129K | 50.0% |
| Total | $4.99 avg | 51,606 | $258K | 100% |
| Filing → |
| IMGN | SELL | 2018-09-11 | $111K | — | Filing → |
| IMGN | SELL | 2018-02-23 | $377K | — | Filing → |
| IMGN | SELL | 2017-09-18 | $11K | — | Filing → |